Compare
Milestone Scientific Inc. vs Jin Medical International Ltd. vs ENvue Medical, Inc. vs CollPlant Biotechnologies Ltd
| Latest fiscal year | Milestone Scientific Inc. MLSS | Jin Medical International Ltd. ZJYL | ENvue Medical, Inc. FEED | CollPlant Biotechnologies Ltd OPHI |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-09-30 | 2025-12-31 | 2025-12-31 |
| Revenue | $8.97M | $20.69M | $2.55M | $2.37M |
| Revenue growth (YoY) | +4.0% | -12.0% | -0.2% | +360.4% |
| Gross margin | 71.4% | 29.2% | 6.0% | 64.8% |
| Operating margin | -63.5% | 2.9% | -896.6% | -484.3% |
| Net margin | -63.8% | 5.8% | -712.3% | -484.6% |
| Net income | -$5.72M | $1.19M | -$18.18M | -$11.49M |
| EPS (Diluted) | -$0.07 | $0.01 | -$26.69 | -$0.94 |
| Operating cash flow | -$2.92M | $2.90M | -$9.37M | -$9.42M |
| Free cash flow | -$2.93M | -$3.73M | -$9.43M | -$9.45M |
| Cash & equivalents | $1.11M | n/a | $4.22M | $5.59M |
| Total assets | $7.81M | $53.37M | $41.12M | $10.79M |
| Total liabilities | $4.99M | $23.80M | $7.63M | $4.70M |
| Shareholders' equity | $2.81M | $29.57M | $33.50M | $6.08M |
| Return on year-end equity | -203.4% | 4.0% | -54.3% | -188.9% |
| Shares outstanding | 80.45M | 156.55M | 1.10M | 12.80M |
Revenue, most recent five fiscal years
| Fiscal year | Milestone Scientific Inc. | Jin Medical International Ltd. | ENvue Medical, Inc. | CollPlant Biotechnologies Ltd |
|---|---|---|---|---|
| Latest | $8.97M Ended 2025-12-31 | $20.69M Ended 2025-09-30 | $2.55M Ended 2025-12-31 | $2.37M Ended 2025-12-31 |
| 1 year earlier | $8.63M Ended 2024-12-31 | $23.50M Ended 2024-09-30 | $2.56M Ended 2024-12-31 | $515.0K Ended 2024-12-31 |
| 2 years earlier | $9.83M Ended 2023-12-31 | $19.82M Ended 2023-09-30 | $2.28M Ended 2023-12-31 | $10.96M Ended 2023-12-31 |
| 3 years earlier | $8.81M Ended 2022-12-31 | $19.19M Ended 2022-09-30 | $752.0K Ended 2022-12-31 | $299.0K Ended 2022-12-31 |
| 4 years earlier | $10.30M Ended 2021-12-31 | $20.76M Ended 2021-09-30 | $1.70M Ended 2021-12-31 | $15.64M Ended 2021-12-31 |